Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
Venkata Viswanadh Edara, William Henry Hudson, Xuping Xie, Rafi Ahmed, Mehul S. Suthar
Abstract
Serum neutralizing antibodies rapidly appear after SARS-CoV-2 infection 1 and vaccination 2 and are maintained for several months. The emergence of SARS-CoV-2 variants has raised concerns about the breadth of neutralizingantibody responses. We compared the neutralizing-antibody response to 4 variants in infected and vaccinated individuals to determine how mutations within the spike protein are associated with virus neutralization.
Topics & Concepts
MedicineVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Vaccination2019-20 coronavirus outbreakAntibodyCoronavirus InfectionsBetacoronavirusAntibody responseNeutralizing antibodySars virusImmunologyVirusOutbreakInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Impact on Reproduction